Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
0
Participant gender:
All
Summary
The study is designed to assess the efficacy of an investigational drug called SR121463B
(vasopressin receptor antagonist) in the treatment of low levels of sodium in the blood
associated with the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).
This double blind period study is followed by 2 open label extension studies with flexible
doses of satavaptan.